TTI-1612

· Trillium Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTI-1612, covering 2013-06-26 to 2013-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome [Phase 1]

See pricing